Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S

 

 

Dr. Chandrashekara. S discussed the use of tofacitinib in ankylosing spondylitis. In December 2021, U.S. FDA has approved the tofacitinib use to treat ankylosing spondylitis patients who are less responsive to TNF blockers. Tofacitinib has beneficial effects in treating ankylosing spondylitis i.e., it improves back stiffness in axial and peripheral disease.

1 thought on “Use of Tofacitinib in Ankylosing Spondylitis by Dr. Chandrashekara S”

Comments are closed.

error: Content is protected !!